These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 657195)

  • 21. [HBe Ag/anti-HBe system: results of a study of 66 patients having the hepatitis B surface antigen (HBsAG)].
    Lemaire JM; Borgeot C; Mourrut C; Michel H
    Nouv Presse Med; 1978 Sep; 7(32):2878. PubMed ID: 714681
    [No Abstract]   [Full Text] [Related]  

  • 22. [Study of Australia antigen in chronic hepatitis, hepatic cirrhosis and acute hepatitis cured without defect].
    Buligescu L; Lenkei R; Dumitriu M; Focşeneanu V
    Med Interna (Bucur); 1973 Jun; 25(6):699-710. PubMed ID: 4793941
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical and etiological study of chronic hepatitis and postnecrotic cirrhosis].
    Acuña R; Velasco M; Puelma E; Katz R; González M; Latorre R
    Rev Med Chil; 1985 Oct; 113(10):978-82. PubMed ID: 3837289
    [No Abstract]   [Full Text] [Related]  

  • 24. [Morphological demonstration of hepatitis B virus surface antigen in liver cirrhosis, fibrosis and hepatocellular carcinoma (author's transl)].
    Chlumská A; Kautzner J
    Cas Lek Cesk; 1981 Jun; 120(23):689-92. PubMed ID: 6265089
    [No Abstract]   [Full Text] [Related]  

  • 25. Hepatitis B antigen and hepatic cirrhosis in tropics.
    Singh DS; Sama SK; Tandon BN; Singh G
    J Assoc Physicians India; 1976 Sep; 24(9):593-7. PubMed ID: 1025144
    [No Abstract]   [Full Text] [Related]  

  • 26. Distribution patterns of hepatitis B antigen in the liver. Immunofluorescence studies.
    Akeyama T; Kamada T; Koyama M; Abe H
    Arch Pathol; 1974 Oct; 98(4):252-6. PubMed ID: 4369930
    [No Abstract]   [Full Text] [Related]  

  • 27. [Presence of Australia antigen, histocompatibility (HL-A) antigens, and autolymphocytotoxins (CoCoCy) during different forms of hepatitis and cirrhosis].
    Bertrams J; Kuwert E; Reis HE; Selmair H; Wiese W
    Zentralbl Bakteriol Orig A; 1974; 227(1-4):372-7. PubMed ID: 4154614
    [No Abstract]   [Full Text] [Related]  

  • 28. [Seroimmune aspects of chronic hepatitis and cirrhosis with and without Australia antigen (AgAu)].
    Oproiu C; Aposteanu G; State I; Hoancă O; Tacorian S; Runcan V
    Med Interna (Bucur); 1972 Jun; 24(6):711-9. PubMed ID: 4115974
    [No Abstract]   [Full Text] [Related]  

  • 29. [Morphology, clinical expression and immunopathology of hepatitis B in infancy and childhood (author's transl)].
    Baumann W; Arnold W; Meyer zum Büschenfelde KH
    Monatsschr Kinderheilkd; 1980 Aug; 128(8):518-34. PubMed ID: 6107831
    [No Abstract]   [Full Text] [Related]  

  • 30. [Autoantibodies and Australia antigen in acute and chronic liver].
    Fargion SR; Del Ninno E; Cappellini MD; Fiorelli G
    Minerva Med; 1974 Feb; 65(13):723-8. PubMed ID: 4545217
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunoserological aspects of chronic hepatitis and hepatic cirrhosis.
    Baltă N; Lenkeli R; Babeş VT; Focşeneanu V; Dan ME
    Med Interne; 1975; 13(3):191-7. PubMed ID: 1242541
    [No Abstract]   [Full Text] [Related]  

  • 32. [Interpretation possibilities of the presence of Australia antigen (Au. an.) in patients with chronic hepatitis and hepatic cirrhosis].
    Turcu E; Efanov A; Macarie C
    Med Interna (Bucur); 1973 Sep; 25(9):1127-34. PubMed ID: 4209305
    [No Abstract]   [Full Text] [Related]  

  • 33. [Australia antigen-positive postnecrotic cirrhosis masquerading as acute viral hepatitis].
    Enat R; Edoute Y; Barzilai D
    Harefuah; 1975 Dec; 89(12):567-9. PubMed ID: 1218837
    [No Abstract]   [Full Text] [Related]  

  • 34. [Hepatitis B antigen in the serum in chronic liver diseases and malignant hepatoma].
    Libman E; Stojsić S; Marton B; Lemberger J
    Med Pregl; 1981; 34(9-10):389-92. PubMed ID: 6281636
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hepatitis-associated antigen in hospitalized patients].
    Skinhoj P
    Ugeskr Laeger; 1971 Sep; 133(37):1830-2. PubMed ID: 5122526
    [No Abstract]   [Full Text] [Related]  

  • 36. [HLA antigens, A, B, and C in venous thromboembolic disease (author's transl)].
    Riedel M; Ivasková E; Sajdlová H
    Cas Lek Cesk; 1981 Jul; 120(29-30):909-13. PubMed ID: 6942929
    [No Abstract]   [Full Text] [Related]  

  • 37. [Current aspects and problems connected with Australia antigen].
    Balş MG
    Med Interna (Bucur); 1972 Jun; 24(6):705-10. PubMed ID: 5069809
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunological aspects of hepatitis and cirrhosis.
    Smith M; Williams R
    Practitioner; 1973 May; 210(259):633-44. PubMed ID: 4593626
    [No Abstract]   [Full Text] [Related]  

  • 39. [The significance of the hepatitis B virus in the development of chronic liver diseases].
    Khazanov AI; Ivlev AS; Rumiantsev ON; Gerasimov GM
    Voen Med Zh; 1988 Nov; (11):59-60. PubMed ID: 3227683
    [No Abstract]   [Full Text] [Related]  

  • 40. [HLA antigens in chronic active liver diseases].
    Loginov AS; Krel' PE; Fedrunova VS; Pevnitskiĭ LA
    Ter Arkh; 1981; 53(6):110-3. PubMed ID: 7281021
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.